{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-071716","form_type":"8-K","ticker":"HOOK","cik":"0001760542","company_name":"HOOKIPA Pharma Inc.","filed_at":"2025-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.902313+00:00","generated_at":"2026-05-17T23:46:00.979948+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"HOOKIPA shareholders approve asset sale to Gilead and company dissolution","bullets":["Asset sale to Gilead Sciences approved: 5,063,462 for, 239,595 against, 1,502 abstain.","Plan of liquidation and dissolution approved: 4,969,875 for, 329,803 against, 4,881 abstain.","Adjournment proposal approved: 5,110,153 for, 191,383 against, 3,023 abstain.","Special meeting held July 29, 2025; 54.13% of outstanding shares voted.","Company will proceed with dissolution following asset sale closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-071716","json":"https://secwatch.observer/filing/0001104659-25-071716.json","markdown":"https://secwatch.observer/filing/0001104659-25-071716.md","text":"https://secwatch.observer/filing/0001104659-25-071716.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1760542/000110465925071716/0001104659-25-071716-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1760542/000110465925071716/tm2521991d7_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T23:46:00.979948+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}